Oxford Nanopore Technologies plc, a company providing next-generation nanopore-based molecular sensing technology, and Saphetor, a next-generation sequencing data analysis company, today announce a new partnership to support supports comprehensive analysis of nanopore sequencing data and enables comprehensive analysis of nanopore sequencing data. -end of workflow. The collaboration with Saphetor will […]
Hitesh
Henry Schein Completes Acquisition of a Majority Interest in Shield Healthcare, Inc.
Henry Schein, Inc., the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced that it has completed the acquisition of Shield Healthcare, Inc., Leading provider of home care medical products delivered directly to patients in their homes. Henry Schein announced an agreement to acquire Shield Healthcare […]
Verily and OneOncology Announce Collaboration to Advance Cancer Research
Verily, a precision medical technology company of Alphabet, and OneOncology, the national platform for independent oncology practice, have established a strategic partnership that enables more effective clinical trials. As part of the agreement, Verily will integrate the clinical trial management software (CTMS) platform, SignalPath, with all operations in the OneOncology […]
Simplify Healthcare Is Positioned in the Leaders Category in the 2023 IDC MarketScape for U.S. Health Plan Product/Plan Benefit Configuration Solutions
Simplify Healthcare, a leading healthcare billing technology company, has announced that it has been ranked in the IDC MarketScape 2023 Leader category for Program Benefits/Product Configuration Solutions healthcare in the United States. The vendors in this study provide stand-alone product/package configuration solutions to payers and TPA organizations, whether they support […]
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
ADARx Pharmaceuticals, Inc., a clinical-stage biotech company developing next-generation RNA-based therapies, today announced the successful conclusion of its over-subscribed Series C funding. value of 200 million dollars. The funding was led by Bain Capital Life Science and TCGX and includes new investors Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare […]
Hims & Hers Expands Into Cardiovascular Health with New Dual-Action Capabilities
Hims & Hers Health, Inc., the leading health and wellness platform, today announced a new approach for providers to personalize sexual health treatment for men. as well as supporting heart health. Through Heart Health by Hims, providers will be able to customize treatments to combine the active ingredients in clinically […]
Bright Health Group Secures Financing to Support Operations Pending the Expected Close of California Medicare Advantage Business Sale
Bright Health Group, Inc., the value-driven, technology-driven healthcare company, today announced that it has entered into a credit facility with an investment partnership of New Enterprise Associates ( “NEA ) with a credit facility of $60 million on August 4, 2023 Bright Health also announced that it has entered into […]
Henry Schein Acquires a Majority Interest in Large Practice Sales LLC, a Leading Transaction Advisory Services Business
Henry Schein, Inc., the world’s largest provider of healthcare products and solutions to in-office medical and dental practitioners, today announced the acquisition of controlling interest in Large Practice Sales LLC (LPS), a leading advisor for their independent dental practices. sell or partner with larger general practitioners and dental professionals. Headquartered […]
Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
Guardant Health, Inc., a leader in precision oncology, today announced an agreement with Illumina Inc., a global leader in DNA sequencing and chip-based technologies, helps resolve their ongoing litigation and drive joint resolution to foster long-term business partnerships. length of companies. The three-year agreement includes a joint request to dismiss […]
Medisca is expanding strategic partnerships to improve patient access to much-needed medicines
Medisca has announced the expansion of a network of strategic partnerships designed to secure and stabilize global access to high quality active pharmaceutical ingredients (APIs) for the manufacture of important drugs. The start of this mission marks USP Exclusive Thyroid Partners in 2021, which has now expanded to Progesterone USP […]
